175 related articles for article (PubMed ID: 29233296)
1. Protein-protein and protein-chromatin interactions of LEDGF/p75 as novel drug targets.
Blokken J; De Rijck J; Christ F; Debyser Z
Drug Discov Today Technol; 2017 Jun; 24():25-31. PubMed ID: 29233296
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.
Llano M; Vanegas M; Hutchins N; Thompson D; Delgado S; Poeschla EM
J Mol Biol; 2006 Jul; 360(4):760-73. PubMed ID: 16793062
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 integrase modulates the interaction of the HIV-1 cellular cofactor LEDGF/p75 with chromatin.
Astiazaran P; Bueno MT; Morales E; Kugelman JR; Garcia-Rivera JA; Llano M
Retrovirology; 2011 Apr; 8():27. PubMed ID: 21510906
[TBL] [Abstract][Full Text] [Related]
4. The Structure-Specific Recognition Protein 1 Associates with Lens Epithelium-Derived Growth Factor Proteins and Modulates HIV-1 Replication.
Lopez AP; Kugelman JR; Garcia-Rivera J; Urias E; Salinas SA; Fernandez-Zapico ME; Llano M
J Mol Biol; 2016 Jul; 428(14):2814-31. PubMed ID: 27216501
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.
Zheng Y; Ao Z; Jayappa KD; Yao X
Virol J; 2010 Mar; 7():68. PubMed ID: 20331877
[TBL] [Abstract][Full Text] [Related]
6. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering.
Vanegas M; Llano M; Delgado S; Thompson D; Peretz M; Poeschla E
J Cell Sci; 2005 Apr; 118(Pt 8):1733-43. PubMed ID: 15797927
[TBL] [Abstract][Full Text] [Related]
7. Chromatinized templates reveal the requirement for the LEDGF/p75 PWWP domain during HIV-1 integration in vitro.
Botbol Y; Raghavendra NK; Rahman S; Engelman A; Lavigne M
Nucleic Acids Res; 2008 Mar; 36(4):1237-46. PubMed ID: 18174227
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional co-activator LEDGF/p75 displays a dynamic scan-and-lock mechanism for chromatin tethering.
Hendrix J; Gijsbers R; De Rijck J; Voet A; Hotta J; McNeely M; Hofkens J; Debyser Z; Engelborghs Y
Nucleic Acids Res; 2011 Mar; 39(4):1310-25. PubMed ID: 20974633
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Lens Epithelium-Derived Growth Factor p75 Dimerization on Its Tethering Function.
Brouns T; Lux V; Van Belle S; Christ F; Veverka V; Debyser Z
Cells; 2024 Jan; 13(3):. PubMed ID: 38334618
[TBL] [Abstract][Full Text] [Related]
10. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
Christ F; Debyser Z
Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
[TBL] [Abstract][Full Text] [Related]
11. TOX4 and NOVA1 proteins are partners of the LEDGF PWWP domain and affect HIV-1 replication.
Morchikh M; Naughtin M; Di Nunzio F; Xavier J; Charneau P; Jacob Y; Lavigne M
PLoS One; 2013; 8(11):e81217. PubMed ID: 24312278
[TBL] [Abstract][Full Text] [Related]
12. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.
Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F
J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426
[TBL] [Abstract][Full Text] [Related]
13. Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase.
Cherepanov P; Devroe E; Silver PA; Engelman A
J Biol Chem; 2004 Nov; 279(47):48883-92. PubMed ID: 15371438
[TBL] [Abstract][Full Text] [Related]
14. Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif.
Tesina P; Čermáková K; Hořejší M; Procházková K; Fábry M; Sharma S; Christ F; Demeulemeester J; Debyser Z; Rijck J; Veverka V; Řezáčová P
Nat Commun; 2015 Aug; 6():7968. PubMed ID: 26245978
[TBL] [Abstract][Full Text] [Related]
15. Implication of serine residues 271, 273, and 275 in the human immunodeficiency virus type 1 cofactor activity of lens epithelium-derived growth factor/p75.
Garcia-Rivera JA; Bueno MT; Morales E; Kugelman JR; Rodriguez DF; Llano M
J Virol; 2010 Jan; 84(2):740-52. PubMed ID: 19889764
[TBL] [Abstract][Full Text] [Related]
16. Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.
Cermáková K; Tesina P; Demeulemeester J; El Ashkar S; Méreau H; Schwaller J; Rezáčová P; Veverka V; De Rijck J
Cancer Res; 2014 Sep; 74(18):5139-51. PubMed ID: 25082813
[TBL] [Abstract][Full Text] [Related]
17. Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: insights from molecular dynamics simulations and the informational spectrum method.
Tintori C; Veljkovic N; Veljkovic V; Botta M
Proteins; 2010 Dec; 78(16):3396-408. PubMed ID: 20878714
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the ternary complex formed by c-Myc interactor JPO2, transcriptional co-activator LEDGF/p75, and chromatin.
Hendrix J; van Heertum B; Vanstreels E; Daelemans D; De Rijck J
J Biol Chem; 2014 May; 289(18):12494-506. PubMed ID: 24634210
[TBL] [Abstract][Full Text] [Related]
19. In vitro DNA tethering of HIV-1 integrase by the transcriptional coactivator LEDGF/p75.
McNeely M; Hendrix J; Busschots K; Boons E; Deleersnijder A; Gerard M; Christ F; Debyser Z
J Mol Biol; 2011 Jul; 410(5):811-30. PubMed ID: 21763490
[TBL] [Abstract][Full Text] [Related]
20. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].
Chen WM; Liu XY
Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
